Graves' orbitopathy
Showing 26 - 50 of 159
Glucocorticoids and Bone in Graves' Ophthalmopathy
Active, not recruiting
- Graves Ophthalmopathy
-
Aarhus C, Central Denmark Region, Denmark
- +1 more
Feb 21, 2022
Graves Ophthalmopathy Trial in São Paulo (Orbital decompression)
Completed
- Graves Ophthalmopathy
- Orbital decompression
-
São Paulo, BrazilUniversity of Sao Paulo General Hospital
Aug 11, 2019
Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)
Approved for marketing
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
-
Beverly Hills, California
- +7 more
Mar 13, 2020
Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)
Not yet recruiting
- Thyroid Eye Disease
- VRDN-001 10 mg/kg Drug:
- (no location specified)
Sep 7, 2023
Graves Disease Trial in Hong Kong (Echopulse)
Completed
- Graves Disease
- Echopulse
-
Hong Kong, Hong KongQueen Mary Hospital
May 17, 2022
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Exophthalmos, Orbitopathy, Graves, Surgery Trial (Orbital decompression with ultrasonic bone removal)
Completed
- Exophthalmos
- +2 more
- Orbital decompression with ultrasonic bone removal
- (no location specified)
Jul 18, 2019
Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)
Withdrawn
- Thyroid Associated Ophthalmopathies
- Sodium selenate
- Sugar pill
- (no location specified)
Aug 12, 2021
Thyroid Eye Disease Trial in Beijing (ZB001 for injection)
Not yet recruiting
- Thyroid Eye Disease
- ZB001 for injection
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 7, 2023
Graves' Ophthalmopathy Trial in Canada (RVT-1401)
Completed
- Graves' Ophthalmopathy
-
Vancouver, British Columbia, Canada
- +3 more
Dec 24, 2021
Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral
Active, not recruiting
- Ophthalmopathy, Thyroid-Associated
- Rituximab
- +2 more
-
Gothenburg, Sweden
- +4 more
Sep 17, 2021
Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and
Not yet recruiting
- Thyroid Eye Disease
- peri-levator betamethasone injection
- +3 more
- (no location specified)
Jul 15, 2021
Thyroid Eye Disease Trial in Los Angeles (Hyaluronic Acid Gel injection, Saline injection)
Terminated
- Thyroid Eye Disease
- Hyaluronic Acid Gel injection
- Saline injection
-
Los Angeles, California
- +1 more
Sep 27, 2021
Thyroid Orbitopathy Trial (Selenium, Placebo)
Completed
- Thyroid Orbitopathy
- Selenium
- Placebo
- (no location specified)
Mar 25, 2019
Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 16, 2021
Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via
Terminated
- Graves' Ophthalmopathy (GO)
- RVT-1401 (Administered via subcutaneous injection)
- Placebo (Administered via subcutaneous injection)
-
Beverly Hills, California
- +24 more
Aug 26, 2022
mDixon TSE MRI Sequence And Conventional MRI Sequences In
Completed
- Dysthyroid Ophthalmopathies
-
Paris, Ile De France, FranceFondation Ophtalmologique Adolphe de Rothschild
May 26, 2021
Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'
Completed
- Graves Ophthalmopathy
- +2 more
- Serum antibodies against the IGF-1R
-
Pisa, ItalyEndocrinology Unit I, University of Pisa
Jul 26, 2018
Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon
Recruiting
- Thyroid Eye Disease
- Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
- +2 more
-
Boston, MassachusettsMass Eye and Ear
Feb 8, 2022
Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)
Completed
- Graves Disease
- +13 more
- every week IVMP therapy
- very high doses IVMP therapy
- (no location specified)
Sep 11, 2018
The Effect of Thyroid Hormon Levels on the Corneal Measures
Completed
- Thyroid Disorder
- Corneal Opacity
-
Diyarbakır, TurkeySağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Researc
Feb 12, 2021
Exophthalmos, Graves Ophthalmopathy, Orbital Tumor Trial in Zurich (Exophthalmos measurement)
Recruiting
- Exophthalmos
- +3 more
- Exophthalmos measurement
-
Zurich, SwitzerlandOphthalmology Department, University Hospital Zurich
Jan 10, 2021